|
Assessment and stabilisation of pre-existing medical and mental health conditions
Assess and stabilise pre-existing medical and mental health conditions prior to pregnancy to optimise pregnancy outcomes. Discuss how these pre-existing conditions may affect, or be affected by, a pregnancy. |
Practice point |
6 |
28 June 2024 |
|
Review current medication for potential for teratogenicity in women and their partners
This should include prescribed and over-the-counter medication, vitamins and other supplements. Switch to and stabilise on safe pregnancy alternatives where required.
Any cessation should balance the benefits and risks and may require referral to a specialist for further consideration. |
Practice point |
7 |
28 June 2024 |
|
Vaccination
Check vaccination history and update vaccinations for severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), measles, mumps, rubella, varicella zoster, diphtheria, tetanus and pertussis, as per recommendations published in the Australian immunisation handbook.
Consider hepatitis B, rubella and varicella immunisation for women with incomplete immunity. |
Practice point |
6 |
28 June 2024 |
|
Optimising weight and nutrition
All women, especially those who have become pregnant in adolescence or have closely spaced pregnancies (ie interpregnancy interval less than six months) require nutritional assessment and appropriate intervention (dietary modification, exercise and other therapies) in the preconception period with an emphasis on optimising maternal body mass index (BMI) and micronutrient reserves. |
Practice point |
6 |
28 June 2024 |
|
Folic acid and iodine supplementation
Folic acid supplementation, at least 0.4 mg daily, should be taken, for a minimum of one (1) month before conception and for the first three (3) months of pregnancy. Where there is an increased risk of neural tube defect (anticonvulsant medication, prepregnancy diabetes, previous child with or family history of neural tube defect, BMI >30 kg/m2), a 5-mg daily dose of folic acid should be used.
Dietary supplementation of 150 mcg iodine should be started prior to a planned pregnancy, or as soon as possible after a woman finds out she is pregnant. |
Practice point |
6 |
28 June 2024 |
|
Alcohol consumption and substance use
Provide advice that to prevent harm from alcohol to their unborn child, women who are pregnant or planning a pregnancy should not drink alcohol. Counselling and pharmacotherapy for alcohol and/or substance use should be considered for either or both parents. |
Practice point |
6 |
28 June 2024 |
|
Effects of age on fertility and risk of chromosomal abnormality
Educate women and their partners that despite advances in assisted reproductive technology, the chance of conception decreases and the risks of chromosomal abnormalities and miscarriage increase with maternal age. |
Practice point |
8 |
28 June 2024 |
|
Fertility awareness and optimising conception
Offer women and their partners advice regarding fertility awareness and how to optimise the chance of conception. |
Practice point |
9 |
28 June 2024 |
|
Interpregnancy intervals
Women should be advised to avoid interpregnancy intervals shorter than six months and counselled about the risks of repeat pregnancy sooner than 18 months, especially after a caesarean section. Refer to the Interconception chapter for further information. |
Conditionally recommended |
10 |
28 June 2024 |
|
First antenatal visit
Encourage an early (ideally before 10 weeks) first antenatal appointment, if and when pregnancy occurs. |
Practice point |
7 |
28 June 2024 |
|
Smoking cessation
Identifying women and their partners who smoke, or have recently stopped smoking, at their first contact with a healthcare service, ideally in the preconception setting, is strongly recommended. Enquire about smoking history and current smoking patterns, including exposure to second-hand smoke. This information should be recorded so that it is available for the remainder of the pregnancy. |
Recommended (strong) |
7,11 |
28 June 2024 |